Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus

Abstract Background Diabetes mellitus (DM) often leads to dangerous thromboembolic complications in humans. DM is also a relatively common endocrinopathy of dogs. There is scarce information regarding procoagulant and anticoagulant plasma indicators in this disease. The aim of the study was to evalu...

Full description

Bibliographic Details
Main Authors: Andrzej Milczak, Dagmara Winiarczyk, Stanisław Winiarczyk, Diana Bochyńska, Łukasz Adaszek, Mateusz Winiarczyk, Roman Lechowski
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-022-03179-7
_version_ 1828854154189078528
author Andrzej Milczak
Dagmara Winiarczyk
Stanisław Winiarczyk
Diana Bochyńska
Łukasz Adaszek
Mateusz Winiarczyk
Roman Lechowski
author_facet Andrzej Milczak
Dagmara Winiarczyk
Stanisław Winiarczyk
Diana Bochyńska
Łukasz Adaszek
Mateusz Winiarczyk
Roman Lechowski
author_sort Andrzej Milczak
collection DOAJ
description Abstract Background Diabetes mellitus (DM) often leads to dangerous thromboembolic complications in humans. DM is also a relatively common endocrinopathy of dogs. There is scarce information regarding procoagulant and anticoagulant plasma indicators in this disease. The aim of the study was to evaluate the levels of the selected plasma haemostatic parameters in dogs suffering from diabetes. The study group consisted of 20 dogs meeting all the inclusion criteria, with fasting glycaemia exceeding 11.1 mmol/l. The control group consisted of 15 healthy dogs presented for routine examination. An evaluation of the prothrombin time (PT); and fibrinogen, D-dimer and antithrombin III (ATIII) levels was performed. Results Except for ATIII activity, the haemostatic parameter differences were not statistically significant. High values of ATIII activity were observed in 90% of diabetic dogs. On average, the values amounted to 166.6% and were 31.4% higher than those in the control group. The ATIII activity in the diabetic group was significantly higher than that in the control group (p = 0.0004). Conclusions Here, we report elevated levels of ATIII in diabetic dogs. This finding may suggest the protective role of ATIII against potential thrombotic events. However, the exact role of ATIII in dog diabetes remains unclear.
first_indexed 2024-12-13T00:28:21Z
format Article
id doaj.art-a8822b68d7874a2193047cf2c358e54e
institution Directory Open Access Journal
issn 1746-6148
language English
last_indexed 2024-12-13T00:28:21Z
publishDate 2022-03-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj.art-a8822b68d7874a2193047cf2c358e54e2022-12-22T00:05:23ZengBMCBMC Veterinary Research1746-61482022-03-011811710.1186/s12917-022-03179-7Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitusAndrzej Milczak0Dagmara Winiarczyk1Stanisław Winiarczyk2Diana Bochyńska3Łukasz Adaszek4Mateusz Winiarczyk5Roman Lechowski6Department and Clinic of Animal Internal Diseases, Sub-Department of Internal Diseases of Small Animals, University of Life Sciences in LublinDepartment and Clinic of Animal Internal Diseases, Sub-Department of Internal Diseases of Small Animals, University of Life Sciences in LublinDepartment of Epizootiology and Clinic of Infectious Diseases, University of Life Sciences in LublinUniversity of Cambridge, Queen’s Veterinary SchoolDepartment of Epizootiology and Clinic of Infectious Diseases, University of Life Sciences in LublinDepartment of Vitreoretinal Surgery, Medical University of LublinFaculty of Veterinary Medicine, Department of Small Animal Diseases with Clinic, Warsaw University of Life SciencesAbstract Background Diabetes mellitus (DM) often leads to dangerous thromboembolic complications in humans. DM is also a relatively common endocrinopathy of dogs. There is scarce information regarding procoagulant and anticoagulant plasma indicators in this disease. The aim of the study was to evaluate the levels of the selected plasma haemostatic parameters in dogs suffering from diabetes. The study group consisted of 20 dogs meeting all the inclusion criteria, with fasting glycaemia exceeding 11.1 mmol/l. The control group consisted of 15 healthy dogs presented for routine examination. An evaluation of the prothrombin time (PT); and fibrinogen, D-dimer and antithrombin III (ATIII) levels was performed. Results Except for ATIII activity, the haemostatic parameter differences were not statistically significant. High values of ATIII activity were observed in 90% of diabetic dogs. On average, the values amounted to 166.6% and were 31.4% higher than those in the control group. The ATIII activity in the diabetic group was significantly higher than that in the control group (p = 0.0004). Conclusions Here, we report elevated levels of ATIII in diabetic dogs. This finding may suggest the protective role of ATIII against potential thrombotic events. However, the exact role of ATIII in dog diabetes remains unclear.https://doi.org/10.1186/s12917-022-03179-7Antithrombin IIICanine diabetesDiabetesThrombosisBlood coagulation
spellingShingle Andrzej Milczak
Dagmara Winiarczyk
Stanisław Winiarczyk
Diana Bochyńska
Łukasz Adaszek
Mateusz Winiarczyk
Roman Lechowski
Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
BMC Veterinary Research
Antithrombin III
Canine diabetes
Diabetes
Thrombosis
Blood coagulation
title Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
title_full Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
title_fullStr Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
title_full_unstemmed Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
title_short Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus
title_sort procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin iii levels in canine diabetes mellitus
topic Antithrombin III
Canine diabetes
Diabetes
Thrombosis
Blood coagulation
url https://doi.org/10.1186/s12917-022-03179-7
work_keys_str_mv AT andrzejmilczak procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT dagmarawiniarczyk procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT stanisławwiniarczyk procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT dianabochynska procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT łukaszadaszek procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT mateuszwiniarczyk procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus
AT romanlechowski procoagulantandanticoagulantplasmaindicatorsindiabeticdogsshowingincreasedantithrombiniiilevelsincaninediabetesmellitus